Aims and Scope
ChemMedChem is a biweekly peer-reviewed scientific journal covering medicinal chemistry. It is published by Wiley-VCH on behalf of Chemistry Europe. In addition to original research in the form of full papers and shorter communications, the journal contains review-type articles (reviews, minireviews, patent reviews, essays, highlights) as well as occasional book reviews and conference reports.
Key Metrics
5.6
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.96
5-Year SI
5-year SI
- N/A 2-year SI
- 0.95 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q2
Biochemistry
SJR
- Q2 Biochemistry
- Q2 Pharmacology
- Q2 Drug Discovery
- Q2 Organic Chemistry
- Q2 Molecular Medicine
- Q1 Pharmacology, Toxicology and Pharmaceutics (all)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.89
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
2 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
67%
4 to 6 months
32%
7 to 9 months
1%
Above 9 months
0%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
SJR
Topics Covered
- Drug discovery
- Nucleoside
- Photodynamic therapy
- Myeloid leukemia
- Receptor signaling
- Protease
- Breast cancer
- Lung cancer
- Positron emission tomography
- Staphylococcus aureus
- Biological evaluation
- Antidepressant
- Medicinal chemistry
- Molecular dynamics
- Assay
- Amide
- Escherichia coli
- Enzyme assay
- Cancer therapy
- G protein
Journal Specifications
| Overview | |
| Publisher | WILEY-V C H VERLAG GMBH |
| Language | English |
| Frequency | Semi-monthly |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 2006 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in ChemMedChem ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
De Novo Design of Tryptophan Containing Broad-Spectrum Cationic Antimicrobial Octapeptides.
- 13 Nov 24
- ChemMedChem
-
Full paper
Cyclodextrin Dimers Functionalized with Biotin as Nanocapsules for Active Doxorubicin Delivery Against MCF-7 Breast Cell Line.
- 8 Nov 24
- ChemMedChem
-
Full paper
Synthesis and Biological Evaluation of N-(1H-Indol-6-ylmethyl)benzenesulfonamide Analogs as Metabolic Inhibitors of Mitochondrial ATP Production in Pancreatic Cancer Cells.
- 8 Nov 24
- ChemMedChem
-
Full paper
Investigation of Novel Isatinylhydantoin Derivatives as Potential Anti-Kinetoplastid Agents.
- 8 Nov 24
- ChemMedChem
-
Full paper
Programmable Intelligent DNA Nanoreactors (iDNRs) for in vivo Tumor Diagnosis and Therapy.
- 8 Nov 24
- ChemMedChem
-
Full paper
Enhanced Anti-inflammatory Effects of Diclofenac Delivered Orally via Polyvinylpyrrolidone K30/Silk Fibroin Nanoparticles in a Murine Model of Carrageenan-Induced Paw Edema.
- 8 Nov 24
- ChemMedChem
Scite analysis
Powered by scite_
5.9k articles received 95.7k citations see all
- 2,827 Supporting
- 91,979 Mentioning
- 131 Contrasting
Editorial notices
- 1 Retractions
- 1 Withdrawals
- 50 Corrections
- 25 Errata
- 0 Expression of Concern
FAQs
How long has ChemMedChem been actively publishing?
ChemMedChem has been in operation since 2006 till date.
What is the publishing frequency of ChemMedChem ?
ChemMedChem published with a Semi-monthly frequency.
How many articles did ChemMedChem publish last years ?
In 2023, ChemMedChem published 254 articles.
What is the eISSN & pISSN for ChemMedChem ?
For ChemMedChem,eISSN is 1860-7187 and pISSN is1860-7179.
What is Citescore for ChemMedChem ?
Citescore for ChemMedChem is 5.6.
What is SNIP score for ChemMedChem ?
SNIP score for ChemMedChem is 0.89.
What is the SJR for ChemMedChem ?
SJR for ChemMedChem is Q2.
Who is the publisher of ChemMedChem ?
WILEY-V C H VERLAG GMBH is the publisher of ChemMedChem.